This study is registered with ClinicalTrials.gov, NCT04655755, and is currently enrolling participants. Findings. Between Jan 21, 2021, and Jan 20, 2023, we enrolled 39 patients (nine in phase 1 and ...

The NCAA recently released a study that indicated a decrease in social media abuse targeting student-athletes, including from sports bettors, during March Madness.

These 2 Foods May Help Lower Your Chronic Disease Risk, New Study Says These two beans might have more power than we realized! Lauren Manaker M.S., RDN, LD, CLEC. Fri, June 6, 2025 at 9:39 PM UTC.

Joshua Kushner’s Thrive Capital and investment firm Capital Group have in recent months visited China to learn about its AI industry, joining a growing number of US investors rekindling interest ...

A Tufts University study reveals that high-quality carbohydrates and fiber contribute to healthy aging in older women, reducing chronic disease risks.

EFZO-CONNECT™ is a Phase 2 randomized, double-blind, placebo-controlled, proof-of-concept study to evaluate the efficacy, safety and tolerability of efzofitimod in patients with limited or ...

Among the patients with PD-L1 TPS<1%, IBI363 demonstrated outstanding efficacy signals: in the 1/1.5 mg/kg group (N=10), the confirmed ORR was 30.0% and the DCR was 90.0%, while that of the 3 mg ...

What if you could turn a 60-minute lecture into a study guide, flashcards, a quiz, and even a podcast in minutes? You're in luck, because that's exactly what TurboLearn AI does.. Built by two college ...

The study intends to enroll up to 25 patients at multiple centers in the United States. Patients who complete the study are eligible to participate in a 24-week open-label extension. The primary ...